Novo Nordisk is a Denmark-based pharmaceutical company that also acts as a corporate strategic investor in healthcare and life sciences companies. From its Bagsværd headquarters, it participates in venture financings across biotechnology, pharmaceuticals and HealthTech, including early drug-discovery rounds and later-stage healthcare financings. The investment record supports activity in the United States and Belgium, making it most relevant for founders in life sciences, biotechnology, pharmaceuticals, digital health and diabetes-adjacent care seeking strategic corporate capital.